PDB Short entry for 2C3E HEADER TRANSPORT PROTEIN 06-OCT-05 2C3E TITLE THE BOVINE MITOCHONDRIAL ADP-ATP CARRIER CAVEAT 2C3E CXT A 401 WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP/ATP TRANSLOCASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ADENINE NUCLEOTIDE TRANSLOCATOR 1, ANT 1, ADP-ATP CARRIER COMPND 5 PROTEIN 1, SOLUTE CARRIER FAMILY 25 MEMBER 4, ADP, ATP CARRIER COMPND 6 PROTEIN, HEART ISOFORM T1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 ORGAN: HEART KEYWDS MITOCHONDRIAL CARRIER, NUCLEOTIDE TRANSPORT, MEMBRANE PROTEIN, KEYWDS 2 TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.NURY,C.DAHOUT-GONZALEZ,V.TREZEGUET,G.LAUQUIN,G.BRANDOLIN,E.PEBAY- AUTHOR 2 PEYROULA REVDAT 5 13-DEC-23 2C3E 1 REMARK REVDAT 4 29-JAN-14 2C3E 1 CAVEAT COMPND SOURCE KEYWDS REVDAT 4 2 1 REMARK VERSN HETSYN HETATM REVDAT 4 3 1 CONECT MASTER REVDAT 3 24-FEB-09 2C3E 1 VERSN REVDAT 2 09-NOV-05 2C3E 1 JRNL REVDAT 1 20-OCT-05 2C3E 0 JRNL AUTH H.NURY,C.DAHOUT-GONZALEZ,V.TREZEGUET,G.LAUQUIN,G.BRANDOLIN, JRNL AUTH 2 E.PEBAY-PEYROULA JRNL TITL STRUCTURAL BASIS FOR LIPID-MEDIATED INTERACTIONS BETWEEN JRNL TITL 2 MITOCHONDRIAL ADP/ATP CARRIER MONOMERS. JRNL REF FEBS LETT. V. 579 6031 2005 JRNL REFN ISSN 0014-5793 JRNL PMID 16226253 JRNL DOI 10.1016/J.FEBSLET.2005.09.061 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 9435 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 459 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.013 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1402 REMARK 3 BIN R VALUE (WORKING SET) : 0.3130 REMARK 3 BIN FREE R VALUE : 0.4000 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 0.05 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 80 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.045 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2266 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 249 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 87.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 95.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -33.31900 REMARK 3 B22 (A**2) : -0.00200 REMARK 3 B33 (A**2) : 33.32100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM SIGMAA (A) : 0.42 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.59 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.58 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.830 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 82.85 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CAT-NEW4.PAR REMARK 3 PARAMETER FILE 3 : CDL-ENTIER.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CAT-NEW4.PAR REMARK 3 TOPOLOGY FILE 3 : CDL-ENTIER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2C3E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1290025890. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 3 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : CCP4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9435 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 16.70 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.56000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1OKC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.77000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.77000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 38.12300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.37600 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 38.12300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.37600 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 44.77000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 38.12300 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.37600 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 44.77000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 38.12300 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.37600 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYZES THE EXCHANGE OF ADP AND ATP ACROSS THE REMARK 400 MITOCHONDRIAL INNER MEMBRANE. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 294 REMARK 465 LYS A 295 REMARK 465 PHE A 296 REMARK 465 VAL A 297 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 1 OG REMARK 470 ARG A 170 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 205 CG CD CE NZ REMARK 470 VAL A 207 CG1 CG2 REMARK 470 ILE A 293 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 2 -6.96 167.92 REMARK 500 GLN A 3 28.35 -164.36 REMARK 500 LEU A 5 42.27 33.60 REMARK 500 PHE A 7 -35.97 158.19 REMARK 500 GLU A 47 30.24 -92.72 REMARK 500 LYS A 48 -16.11 -142.06 REMARK 500 ARG A 79 -38.85 -26.44 REMARK 500 GLN A 107 66.16 -160.18 REMARK 500 CYS A 128 -38.52 -27.08 REMARK 500 LYS A 146 -85.54 -91.93 REMARK 500 ALA A 148 4.26 -53.40 REMARK 500 LYS A 165 -0.96 -57.13 REMARK 500 ASP A 167 20.18 -149.10 REMARK 500 ASN A 177 -70.04 -45.39 REMARK 500 PRO A 204 39.00 -89.01 REMARK 500 LYS A 205 -30.24 71.33 REMARK 500 ASN A 206 95.46 -58.88 REMARK 500 VAL A 207 63.26 166.02 REMARK 500 HIS A 208 -109.82 34.37 REMARK 500 ILE A 209 -30.83 179.40 REMARK 500 SER A 241 128.21 -37.59 REMARK 500 ALA A 246 -96.28 53.43 REMARK 500 ILE A 248 97.77 -38.34 REMARK 500 ILE A 260 -77.04 -44.17 REMARK 500 LYS A 262 -74.88 -82.88 REMARK 500 ASP A 291 65.39 -59.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CDL A 800 REMARK 610 CDL A 801 REMARK 610 CDL A 802 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CXT A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL A 802 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OKC RELATED DB: PDB REMARK 900 STRUCTURE OF MITOCHONDRIAL ADP/ATP CARRIER IN COMPLEX WITH REMARK 900 CARBOXYATRACTYLOSIDE DBREF 2C3E A 1 297 UNP P02722 ADT1_BOVIN 1 297 SEQRES 1 A 297 SER ASP GLN ALA LEU SER PHE LEU LYS ASP PHE LEU ALA SEQRES 2 A 297 GLY GLY VAL ALA ALA ALA ILE SER LYS THR ALA VAL ALA SEQRES 3 A 297 PRO ILE GLU ARG VAL LYS LEU LEU LEU GLN VAL GLN HIS SEQRES 4 A 297 ALA SER LYS GLN ILE SER ALA GLU LYS GLN TYR LYS GLY SEQRES 5 A 297 ILE ILE ASP CYS VAL VAL ARG ILE PRO LYS GLU GLN GLY SEQRES 6 A 297 PHE LEU SER PHE TRP ARG GLY ASN LEU ALA ASN VAL ILE SEQRES 7 A 297 ARG TYR PHE PRO THR GLN ALA LEU ASN PHE ALA PHE LYS SEQRES 8 A 297 ASP LYS TYR LYS GLN ILE PHE LEU GLY GLY VAL ASP ARG SEQRES 9 A 297 HIS LYS GLN PHE TRP ARG TYR PHE ALA GLY ASN LEU ALA SEQRES 10 A 297 SER GLY GLY ALA ALA GLY ALA THR SER LEU CYS PHE VAL SEQRES 11 A 297 TYR PRO LEU ASP PHE ALA ARG THR ARG LEU ALA ALA ASP SEQRES 12 A 297 VAL GLY LYS GLY ALA ALA GLN ARG GLU PHE THR GLY LEU SEQRES 13 A 297 GLY ASN CYS ILE THR LYS ILE PHE LYS SER ASP GLY LEU SEQRES 14 A 297 ARG GLY LEU TYR GLN GLY PHE ASN VAL SER VAL GLN GLY SEQRES 15 A 297 ILE ILE ILE TYR ARG ALA ALA TYR PHE GLY VAL TYR ASP SEQRES 16 A 297 THR ALA LYS GLY MET LEU PRO ASP PRO LYS ASN VAL HIS SEQRES 17 A 297 ILE ILE VAL SER TRP MET ILE ALA GLN THR VAL THR ALA SEQRES 18 A 297 VAL ALA GLY LEU VAL SER TYR PRO PHE ASP THR VAL ARG SEQRES 19 A 297 ARG ARG MET MET MET GLN SER GLY ARG LYS GLY ALA ASP SEQRES 20 A 297 ILE MET TYR THR GLY THR VAL ASP CYS TRP ARG LYS ILE SEQRES 21 A 297 ALA LYS ASP GLU GLY PRO LYS ALA PHE PHE LYS GLY ALA SEQRES 22 A 297 TRP SER ASN VAL LEU ARG GLY MET GLY GLY ALA PHE VAL SEQRES 23 A 297 LEU VAL LEU TYR ASP GLU ILE LYS LYS PHE VAL HET CXT A 401 51 HET CDL A 800 62 HET CDL A 801 55 HET CDL A 802 81 HETNAM CXT CARBOXYATRACTYLOSIDE HETNAM CDL CARDIOLIPIN HETSYN CDL DIPHOSPHATIDYL GLYCEROL; BIS-(1,2-DIACYL-SN-GLYCERO-3- HETSYN 2 CDL PHOSPHO)-1',3'-SN-GLYCEROL FORMUL 2 CXT C31 H46 O18 S2 FORMUL 3 CDL 3(C81 H156 O17 P2 2-) HELIX 1 1 PHE A 7 GLN A 38 1 32 HELIX 2 2 HIS A 39 SER A 41 5 3 HELIX 3 3 GLY A 52 GLY A 65 1 14 HELIX 4 4 PHE A 66 ARG A 71 5 6 HELIX 5 5 GLY A 72 LEU A 99 1 28 HELIX 6 6 GLN A 107 ALA A 142 1 36 HELIX 7 7 GLY A 155 TYR A 173 1 19 HELIX 8 8 GLY A 175 LEU A 201 1 27 HELIX 9 9 ILE A 209 SER A 227 1 19 HELIX 10 10 SER A 227 MET A 239 1 13 HELIX 11 11 GLY A 252 GLU A 264 1 13 HELIX 12 12 LYS A 267 LYS A 271 5 5 HELIX 13 13 TRP A 274 ASP A 291 1 18 SITE 1 AC1 13 ARG A 79 ASN A 87 LYS A 91 GLY A 123 SITE 2 AC1 13 SER A 126 LEU A 127 GLY A 182 TYR A 186 SITE 3 AC1 13 ARG A 187 SER A 227 PHE A 230 ASP A 231 SITE 4 AC1 13 ARG A 234 SITE 1 AC2 12 ALA A 19 THR A 23 TRP A 70 ARG A 71 SITE 2 AC2 12 GLY A 72 ASN A 73 LEU A 74 PHE A 81 SITE 3 AC2 12 GLY A 155 LEU A 156 GLY A 157 ASN A 158 SITE 1 AC3 12 LEU A 35 GLY A 52 ILE A 53 ILE A 54 SITE 2 AC3 12 LEU A 225 LYS A 267 PHE A 270 LYS A 271 SITE 3 AC3 12 GLY A 272 ALA A 273 TRP A 274 SER A 275 SITE 1 AC4 12 TYR A 94 THR A 125 CYS A 128 TYR A 173 SITE 2 AC4 12 GLN A 174 GLY A 175 PHE A 176 ASN A 177 SITE 3 AC4 12 GLN A 181 GLY A 252 THR A 253 VAL A 254 CRYST1 76.246 110.752 89.540 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013115 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009029 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011168 0.00000